RecruitingNot ApplicableNCT06080503

Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy

G-FORCE: Phase II Randomized Study of Glottic Larynx Hypofractionated Radiotherapy Versus ConvEntional Radiotherapy


Sponsor

University of Texas Southwestern Medical Center

Enrollment

67 participants

Start Date

Mar 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To compare the acute tolerance of highly conformal hypofractionated versus conventional radiotherapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study compares two radiation therapy schedules for early-stage larynx (voice box) cancer — one uses a shorter, more intense course and the other uses the traditional longer schedule. Researchers want to find out if the shorter approach works just as well. **You may be eligible if...** - You have been diagnosed with squamous cell carcinoma (a type of cancer) of the voice box - Your cancer is early stage (stage 0 to II) with no spread to lymph nodes - You are 18 years or older - You are in reasonably good health and able to function independently - You are willing to use contraception if you could become pregnant **You may NOT be eligible if...** - Your cancer is stage III or IV - Your cancer has spread to a specific cartilage in the throat (arytenoid) - You have already had chemotherapy for this cancer - You have had prior radiation to the same area - You currently smoke more than one pack of cigarettes per day - You have serious uncontrolled health conditions like heart failure or active infection Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONLT-SABR

42.5 Gy in 5 fractions Low-risk: twice/week Moderate-risk: weekly

RADIATIONIMRT

63 Gy in 28 fractions (T1) 65.25 Gy in 29 fractions (T2)


Locations(1)

University of Texas Southwestern Medical Center

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06080503


Related Trials